Literature DB >> 22525660

Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice.

Valeria Paola Carlini1, Daniele Guilhermano Machado, Florencia Buteler, Marisa Ghersi, Marina F Ponzio, Ana Carolina Martini, Helgi B Schiöth, Marta Fiol de Cuneo, Ana Lúcia S Rodrigues, Susana R de Barioglio.   

Abstract

This study aims to examine the antidepressant-like action of Ghrelin (Ghr), a hormone synthesized predominantly by gastrointestinal endocrine cells and released during periods of negative energy balance, in two behavioral models: tail suspension test (TST), a predictive model of antidepressant activity, and the olfactory bulbectomy (OB), an established animal model of depression. The reduction in the immobility time in the TST was the parameter used to assess antidepressant-like effect of Ghr. The depressive-like behavior in olfactory bulbectomized mice was inferred through the increase in the immobility time in the TST and the hyperlocomotor activity in the open-field test. Ghr produced antidepressant-like effect in TST (0.3 nmol/μl, i.c.v.), and reversed OB-induced depressive-like behavior. In conclusion, these results provide clear evidence that an acute administration of ghrelin produce antidepressant-like effect in the TST and OB.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525660     DOI: 10.1016/j.peptides.2012.03.031

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.

Authors:  A K Walker; P D Rivera; Q Wang; J-C Chuang; S Tran; S Osborne-Lawrence; S J Estill; R Starwalt; P Huntington; L Morlock; J Naidoo; N S Williams; J M Ready; A J Eisch; A A Pieper; J M Zigman
Journal:  Mol Psychiatry       Date:  2014-04-22       Impact factor: 15.992

2.  β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress.

Authors:  Deepali Gupta; Jen-Chieh Chuang; Bharath K Mani; Kripa Shankar; Juan A Rodriguez; Sherri Osborne-Lawrence; Nathan P Metzger; Jeffrey M Zigman
Journal:  Neuropsychopharmacology       Date:  2019-02-08       Impact factor: 7.853

Review 3.  "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin.

Authors:  Xi Chen; Jing Dong; Qian Jiao; Xixun Du; Mingxia Bi; Hong Jiang
Journal:  Cell Mol Life Sci       Date:  2022-03-03       Impact factor: 9.261

4.  Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner.

Authors:  Kristina Holubova; Lenka Kleteckova; Martina Skurlova; Jan Ricny; Ales Stuchlik; Karel Vales
Journal:  Psychopharmacology (Berl)       Date:  2016-03-23       Impact factor: 4.530

Review 5.  Potential gut-brain mechanisms behind adverse mental health outcomes of bariatric surgery.

Authors:  Robyn M Brown; Eva Guerrero-Hreins; Wendy A Brown; Carel W le Roux; Priya Sumithran
Journal:  Nat Rev Endocrinol       Date:  2021-07-14       Impact factor: 43.330

Review 6.  The Antidepressant-like Effects of Estrogen-mediated Ghrelin.

Authors:  Pu Wang; Changhong Liu; Lei Liu; Xingyi Zhang; Bingzhong Ren; Bingjin Li
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

7.  Ghrelin produces antidepressant-like effect in the estrogen deficient mice.

Authors:  Jie Fan; Bing Jin Li; Xue Feng Wang; Li Li Zhong; Ran Ji Cui
Journal:  Oncotarget       Date:  2017-08-01

8.  Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.

Authors:  Roland Ricken; Sandra Bopp; Peter Schlattmann; Hubertus Himmerich; Tom Bschor; Christoph Richter; Samuel Elstner; Thomas J Stamm; Brigitte Schulz-Ratei; Alexandra Lingesleben; Friedel M Reischies; Philipp Sterzer; Stefan Borgwardt; Michael Bauer; Andreas Heinz; Rainer Hellweg; Undine E Lang; Mazda Adli
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

Review 9.  The gut-brain-axis as a target to treat stress-induced obesity.

Authors:  Chooi Yeng Lee; Alfonso Abizaid
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-18       Impact factor: 5.555

10.  Centrally Administered Cortistation-14 Induces Antidepressant-Like Effects in Mice via Mediating Ghrelin and GABAA Receptor Signaling Pathway.

Authors:  JinHong Jiang; YaLi Peng; XueYa Liang; Shu Li; Xin Chang; LongFei Li; Min Chang
Journal:  Front Pharmacol       Date:  2018-07-19       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.